Cargando…
Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
The immunohistochemical definition of estrogen/progesterone receptors dictates endocrine feasibility in the treatment course of breast cancer. Characterized by the deficiency of estrogen receptor α, ERα-negative breast cancers are dissociated from any endocrine regimens in the routine clinical setti...
Autores principales: | Li, Kaixuan, Zong, Dongjiang, Sun, Jianrong, Chen, Danxiang, Ma, Minkai, Jia, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280148/ https://www.ncbi.nlm.nih.gov/pubmed/35847875 http://dx.doi.org/10.3389/fonc.2022.830894 |
Ejemplares similares
-
Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
por: Qin, Ruoyan, et al.
Publicado: (2023) -
Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022) -
Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020) -
Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022) -
Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
por: Qin, Wenxing, et al.
Publicado: (2021)